Welcome to our dedicated page for Oracle SEC filings (Ticker: ORCL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to Oracle Corporation’s (ORCL) U.S. Securities and Exchange Commission filings, giving investors a primary source of information on the company’s governance, capital structure, and material events. Oracle’s common stock, par value $0.01 per share, is registered under Section 12(b) of the Exchange Act and listed on the New York Stock Exchange under the symbol ORCL, as disclosed in multiple Forms 8‑K.
Among Oracle’s key filings are current reports on Form 8‑K, which document events such as quarterly financial results, cash dividend declarations, leadership and board changes, and significant financing transactions. Recent 8‑K filings describe press releases announcing fiscal quarter results, the declaration of cash dividends on Oracle’s common stock, the promotion of executives to Chief Executive Officer roles and Principal Financial Officer, the appointment and retirement of directors, and the issuance of senior notes under an existing shelf registration statement.
Oracle’s definitive proxy statement on Schedule 14A (DEF 14A) outlines matters for its annual meeting of stockholders, including the election of directors, an advisory vote on executive compensation, and ratification of its independent registered public accounting firm. The proxy statement also discusses board structure, committees, corporate governance guidelines, stock ownership policies, and executive compensation programs.
Investors may also find Form 25 filings relevant for specific Oracle debt securities. Oracle has filed a Form 25‑NSE relating to the removal from listing of its 3.125% Notes due 2025 from the New York Stock Exchange. This filing concerns a class of notes and is separate from the listing of Oracle’s common stock.
On Stock Titan, Oracle’s SEC filings are organized chronologically and can be paired with AI‑powered summaries that explain the purpose and implications of each document. This helps readers quickly understand items such as 8‑K event descriptions, proxy proposals, and capital markets transactions, while still allowing direct access to the full text of Oracle’s submissions to the SEC.
Oracle Corporation (NYSE: ORCL) filed a Form 25 with the U.S. Securities and Exchange Commission to remove its 3.125% Notes due 2025 from listing and registration on the New York Stock Exchange (NYSE) under Section 12(b) of the Exchange Act. The filing, dated 10 July 2025 and signed by NYSE representative Anthony Sozzi, certifies that the Exchange has satisfied all applicable rules for delisting. The company may also have met the voluntary withdrawal requirements under Rule 12d2-2(c); however, no additional financial or strategic rationale is provided within the document.
Oracle CEO Safra Catz filed Form 144 indicating a proposed sale of 1,260,508 shares of common stock with an aggregate market value of $267.2 million. The shares were acquired through stock options exercise on June 27, 2025, and are planned to be sold through Fidelity Brokerage Services on the NYSE.
The filing reveals significant recent selling activity by Catz in the past week:
- June 20: 2,284,371 shares for $474.2M
- June 23: 1,410,547 shares for $289.8M
- June 25: 1,873,791 shares for $397.8M
- June 26: 1,865,701 shares for $396.9M
The sales are being executed under a 10b5-1 trading plan adopted on September 25, 2024. The shares are being sold from the Harbor Island Joint Rev Trust. Oracle's total shares outstanding are approximately 2.81 billion.